Skip to main content
Advertisement
Advertisement
CAPR
CAPR logo
Capricor Therapeutics Inc
7.53
USD
Sponsored
-0.50
-6.23%
Nov 19, 15:59 UTC -5
Closed
exchange

After-Market

7.66

+0.13
+1.71%

Capricor Therapeutics Inc (CAPR) Earnings

CAPR Earnings Reports

Positive Surprise Ratio

CAPR beat 22 of 41 last estimates.

54%

Next Report

Date of Next Report
Mar 10, 2027
Estimate for Q4 26 (Revenue/ EPS)
$7.52M
/
-$0.21
Implied change from Q3 26 (Revenue/ EPS)
--
/
-71.23%
Implied change from Q4 25 (Revenue/ EPS)
--
/
-66.13%

Capricor Therapeutics Inc earnings per share and revenue

On Nov 10, 2026, CAPR reported earnings of -0.73 USD per share (EPS) for Q3 26, missing the estimate of -0.44 USD, resulting in a -65.16% surprise. Revenue reached --, compared to an expected 42.55 million, with a -100.00% difference. The market reacted with a +26.49% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.21 USD, with revenue projected to reach 7.52 million USD, implying an decrease of -71.23% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%
logo
Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%
logo
Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%
logo
MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%
logo
Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%
logo
Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-
Actual
$0.10
Surprise
-
logo
FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%
logo
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%
logo
Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%
logo
Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
For Q3 2026, Capricor Therapeutics Inc reported EPS of -$0.73, missing estimates by -65.16%, and revenue of $0.00, -100% below expectations.
The stock price moved up 26.49%, changed from $8.87 before the earnings release to $11.22 the day after.
The next earning report is scheduled for Mar 10, 2027.
Based on -- analysts, Capricor Therapeutics Inc is expected to report EPS of -$0.21 and revenue of $7.52M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement